Patents by Inventor Boadie W. Dunlop

Boadie W. Dunlop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSESSMENT AND TREATMENT OF DEPRESSION, ANXIETY, OR RELATED DISORDERS
    Publication number: 20240197795
    Abstract: Described herein are methods of identifying, characterizing, and treating depression and anxiety in a subject by modulating indoles associated with tryptophan metabolism in the subject and subject's gut microbiome.
    Type: Application
    Filed: July 27, 2021
    Publication date: June 20, 2024
    Inventors: Rima F. Kaddurah-Daouk, Augustus John Rush, JR., Boadie W. Dunlop, Oliver Fiehn, Christopher R. Brydges, W. Edward Craighead, Helen Mayberg
  • METHODS AND COMPOSITIONS FOR DIAGNOSING DEPRESSION
    Publication number: 20220187315
    Abstract: Described herein are methods and composition for diagnosing and evaluating the treatment of depression using one or more biomarker metabolites for the diagnosis and monitoring treatment efficacy. In one aspect, the biomarker metabolites can be used to screen subjects for the likelihood of developing depression, the diagnosis thereof, monitoring the efficacy of treatment, and evaluating a subject's propensity for responding to treatment.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 16, 2022
    Inventors: Rima F. Kaddurah-Daouk, Augustus John Rush, Jr., Siamak Mahmoudian Dehkordi, Sudeepa Bhattcharyya, Ranga R. Krishnan, Mark A. Frye, Ahmed T. Ahmed, Richard M. Weinshilboum, Boadie W. Dunlop, Wei Jia